血清学检测和聚合酶链反应在急性和慢性巨细胞病毒感染监测中的比较

doi:10.3969/j.issn.1673-8640.2016.06.005

摘要/Abstract

摘要：

目的比较血清学（免疫化学发光法）巨细胞病毒（CMV）特异性抗体检测和实时荧光聚合酶链反应（PCR）定性CMV DNA检测对监测CMV急性和慢性感染的意义。方法回顾性分析临床疑似CMV感染的患者361例,单独或同时出现非特异性症状和体征,发热、白细胞减少症、高胆红素血症和丙氨酸氨基转移酶升高等都被视为疑似CMV感染。疑似患者同步检测CMV IgM、IgG抗体和CMV DNA。结果只有7例CMV IgM抗体和CMV DNA检测结果均为阳性,13例CMV IgM抗体阳性而CMV DNA阴性,23例CMV IgM 抗体阴性而CMV DNA阳性,2种检测方法结果缺乏一致性（Kappa=0.229,P<0.05）。将327例仅CMV IgG抗体阳性病例按CMV DNA检测结果分为2个组,即CMV DNA阴性300例和CMV DNA阳性27例,其CMV IgG抗体浓度在2个组间差异无统计学意义[中位数（四分位数）分别为195.24（73.80,250.00）和221.90（129.60,250.00） AU/mL,P=0.137]。结论血清学检测CMV抗体对于诊断活动性CMV感染不敏感,与CMV DNA结果的一致性较差,同时也不能用于CMV感染慢性期的监测。在判断CMV感染的临床应用中,应结合CMV DNA和CMV抗体检测（包括IgG滴度变化）综合评价。

关键词: 巨细胞病毒, 血清学检测, 聚合酶链反应

Abstract:

Objective To compare serological assay（chemiluminescence immunoassay） in cytomegalovirus（CMV） antibody determination and real-time fluorescence polymerase chain reaction（PCR） in qualitative CMV DNA determination for the monitoring of acute and chronic CMV infections. Methods A total of 361 patients suspected with CMV infections were analyzed retrospectively. Patients suspected with CMV infections were determined on the bases of nonspecific symptoms,including fever,leukopenia,hyperbilirubinemia and alanine aminotransferase elevation,alone or in combination. All patients were screened for CMV IgM and IgG antibodies and CMV DNA. Results CMV IgM antibody and CMV DNA by the 2 methods were all positive in only 7 patients. A total of 13 patients were positive for CMV IgM antibody and negative for CMV DNA,23 patients were positive for CMV DNA and negative for CMV IgM antibody. There was no consistency between the 2 methods（Kappa=0.229,P<0.05）. Furthermore,327 patients with positive CMV IgG antibody were classified into CMV DNA negative group（300 cases） and CMV DNA positive group（27 cases） according to CMV DNA determination results,and there was no statistical significance for CMV IgG antibody level [medians（quartiles） were 195.24（73.80,250.00） and 221.90（129.60,250.00） AU/mL,P=0.137]. Conclusions Having poor consistency with CMV DNA determination results,serological assay for CMV antibodies is not sensitive enough to diagnose acute CMV infection and cannot be used for monitoring CMV infections during the chronic period. The clinical diagnosis of CMV infections should be evaluated by the combination determination of CMV DNA and CMV antibodies,including the quantitation of CMV IgG.

Key words: Cytomegalovirus, Serological assay, Polymerase chain reaction

中图分类号:

R446.61

陈雁汶, 胡尧. 血清学检测和聚合酶链反应在急性和慢性巨细胞病毒感染监测中的比较[J]. 检验医学, 2016, 31(6): 458-461.

CHEN Yanwen, HU Yao. Comparison of serological assay and polymerase chain reaction for the monitoring of acute and chronic cytomegalovirus infections[J]. Laboratory Medicine, 2016, 31(6): 458-461.

图/表 2

参考文献 19

[1]	CROUGH T,KHANNA R.Immunobiology of human cytomegalovirus: from bench to bedside[J]. Clin Microbiol Rev,2009,22(1):76-98.
[2]	BRENNAN DC.Cytomegalovirus in renal transplantation[J]. J Am Soc Nephrol,2001,12(4):848-855.
[3]	HUMAR A,SNYDMAN D,AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplant recipients[J]. Am J Transplant,2009,9(Suppl 4):S78-S86.
[4]	OSAWA R,SINGH N.Cytomegalovirus infection in critically ill patients: a systematic review[J]. Crit Care,2009,13(3):R68.
[5]	CROUGH T,KHANNA R.Immunobiology of human cytomegalovirus: from bench to bedside[J]. Clin Microbiol Rev,2009,22(1):76-98.
[6]	Caring for Australians with Renal Impairment(CARI). The CARI guidelines. CMV disease and kidney transplant:diagnostic tests for cytomegalovirus in renal transplantation[J]. Nephrology(Carlton),2004,9(Suppl 3):S23-S26.
[7]	SOLA R,RABELLA N,GUIRADO LL,et al.Relation between pp65 antigenemia,RT-PCR and viruria for cytomegalovirus detection in kidney transplant recipients[J]. Transplant Proc,2005,37(9):3768-3769.
[8]	PASS RF,GRIFFITHS PD,AUGUST AM.Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections[J]. J Infect Dis,1983,147(1):40-46.
[9]	NAUMNIK B,MALYSZKO J,CHYCZEWSKI L,et al.Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients[J].Transplant Proc, 2007,39(9):2748-2750.
[10]	BASSON J,TARDY JC,AYMARD M.Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. A study of kidney graft recipients developing a primary or recurrent CMV infection[J]. Arch Virol,2005,108(3-4):259-270.
[11]	LENG SX,QU T,SEMBA RD,et al.Relationship between cytomegalovirus(CMV) IgG serology,detectable CMV DNA in peripheral monocytes,and CMV pp65(495-503)-specific CD8+ T cells in older adults[J]. Age(Dordr),2011,33(4):607-614.
[12]	MARSANO L,PERRILLO RP,FLYE MW,et al.Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients[J]. J Infect Dis,1990,161(3):454-461.
[13]	RAZONABLE RR,PAYA CV,SMITH TF.Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients[J]. J Clin Microbiol,2002,40(3):746-752.
[14]	PIIPARINEN H,HELANTER I,LAPPALAINEN M,et al.Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients[J]. J Med Virol,2005,76(3):367-372.
[15]	LAZZAROTTO T,GALLI C,PULVIRENTI R,et a1.Evaluation of the Abbott AxSYM cytomegalovirus(CMV)immunoglobulin M (IgM)assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay[J].Clin Diagn Lab Immunol,2001,8(1):196-198.
[16]	GOEGEBUER T,VAN MEENSEL B,BEUSELINCK K, et al.Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples[J]. J Clin Microbiol,2009,47(3):660-665.
[17]	KOTTON CN,KUMAR D,CALIENDO AM,et al.International consensus guidelines on the management of cytomegalovirus in solid organ transplantation[J]. Transplantation,2010,89(7):779-795.
[18]	LI H,DUMMER JS,ESTES WR,et al.Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients[J]. J Clin Microbiol,2003,41(1):187-191.
[19]	GARRIGUE I,BOUCHER S,COUZI L,et al.Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients[J]. J Clin Virol, 2006,36(1):72-75.

血清学检测	PCR		合计
血清学检测	CMV DNA 阳性	CMV DNA 阴性	合计
CMV IgM 阳性	7	13	20
CMV IgM 阴性	23	318	341
合计	30	331	361

血清学检测	PCR		合计
血清学检测	CMV DNA 阳性	CMV DNA 阴性	合计
CMV IgM 阳性	7	13	20
CMV IgM 阴性	23	318	341
合计	30	331	361

组别	CMV IgG
组别	阳性（例）	定量（AU / mL）
CMV DNA 阳性组	27	221.90（129.60,250.00）
CMV DNA 阴性组	300	195.24（73.80,250.00）

组别	CMV IgG
组别	阳性（例）	定量（AU / mL）
CMV DNA 阳性组	27	221.90（129.60,250.00）
CMV DNA 阴性组	300	195.24（73.80,250.00）